Immune response after intramammary challenge with Streptococcus uberis mastitis for cows fed OmniGen-AF® during mid-lactation

dc.contributor.advisorKohn, Richarden_US
dc.contributor.authorFischer, Amandaen_US
dc.contributor.departmentAnimal Sciencesen_US
dc.contributor.publisherDigital Repository at the University of Marylanden_US
dc.contributor.publisherUniversity of Maryland (College Park, Md.)en_US
dc.date.accessioned2022-02-04T06:43:07Z
dc.date.available2022-02-04T06:43:07Z
dc.date.issued2021en_US
dc.description.abstractMastitis is one of the costliest diseases in the dairy cattle industry. Environmental pathogens, such as Streptococcus uberis (Strep. uberis), are the most prevalent causes of mastitis infections, while contagious pathogen mastitis has declined in incidences due to improvement in management protocols. Antimicrobials and antibiotics are the primary therapies currently utilized in the dairy industry to treat mastitis. However, the concern for antibiotic overuse and potential bacterial resistance due to improper use of these therapies has steered research in exploration of alternatives to antibiotics or other strategies. One potential alternative is supplementation of an immunomodulatory feed additive to daily cattle total mixed rations (TMR). A current immunomodulator is OmniGen-AF ® (OMN) produced by Phibro Animal Health Corporation (Teaneck, NJ) and has been explored being fed to lactating dairy cattle by previous research groups. OmniGen- AF ® has been reported to improve initial innate immune response during infection. However, it is unknown how OMN influences the innate immune system in vivo to a S. uberis mastitis infection. The ability of OMN to modulate immune function during an environmental mastitis infection was tested compared to control groups. Cows fed OmniGen-AF® and challenged with Strep. uberis had numerically higher least squared mean Log somatic cell count compared to the control group that was not fed OMN and challenged with Strep. uberis. OMN fed cows displayed numerically higher average daily feed intake and fluid milk yield values compared to the control group. Further analysis of milk and blood samples using immunoassays to monitor the effects OMN has on cytokine and cortisol levels throughout mastitis infection is needed to determine innate immune response. In conclusion, OmniGen-AF® has the potential as an immunomodulator that improves innate immune system activity with continuous supplementation in the diet to prevention of dairy cattle environmental mastitis.en_US
dc.identifierhttps://doi.org/10.13016/t1l1-wc9f
dc.identifier.urihttp://hdl.handle.net/1903/28491
dc.language.isoenen_US
dc.subject.pqcontrolledAnimal sciencesen_US
dc.subject.pquncontrolleddairyen_US
dc.subject.pquncontrolledholsteinen_US
dc.subject.pquncontrolledimmunomodulatoren_US
dc.subject.pquncontrolledmastitisen_US
dc.titleImmune response after intramammary challenge with Streptococcus uberis mastitis for cows fed OmniGen-AF® during mid-lactationen_US
dc.typeThesisen_US

Files

Original bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
Fischer_umd_0117N_22170.pdf
Size:
1.56 MB
Format:
Adobe Portable Document Format